App-Quantinova.ai

Rivaroxaban Versus Fondaparinux in the Treatment of Superficial Vein Thrombosisa - the Surprise Trial

Jan Beyer-Westendorf - American Society of Hematology (ASH) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

Fondaparinux sodium

Recurrent Thrombosis in Patients with Antiphospholipid Antibodies and Arterial Thrombosis Treated with Antiplatelets and/or Anticoagulant Therapy

William G Jackson - American Society of Hematology (ASH) , 2016

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

N/A

Association of BW with Thromboembolic and Bleeding Outcomes in Phase III Randomized Controlled Trials of Direct Oral Anticoagulants: Systematic Review and Meta-Analysis

Kochawan Boonyawat - American Society of Hematology (ASH) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

The Risk of Major Bleeding with Low-Molecular-Weight-Heparins for Venous Thromboembolism in Dialysis Patients: The Q-VTE Study

Adi J. Klil-Drori - American Society of Hematology (ASH) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Serial Trough Anti-Xa Levels to Assess Low Molecular Weight Heparin Accumulation in Patients with Chronic Kidney Disease: Analysis of Crcl

Wendy Lim - American Society of Hematology (ASH) , 2016

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Venous thrombosis

Tinzaparin

Prediction of Bleeding Risk in Patients on Extended Oral Anticoagulation for Venous Thromboembolism

Philip S Wells - American Society of Hematology (ASH) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Dabigatran Is Associated with a Significantly Lower Risk of Abnormal Uterine Bleeding Than Warfarin in Female Patients of Childbearing Age with Venous Thromboembolism

Frederikus A Klok - American Society of Hematology (ASH) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Pradax

Intracranial Hemorrhage in Patients with Primary Brain Tumors Treated with Therapeutic Enoxaparin: A Matched Cohort Study

Charlene Mantia - American Society of Hematology (ASH) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

Enoxaparin

A Platelet Count

Bethany T Samuelson - American Society of Hematology (ASH) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Randomized Study of Pegasparagase (SS-PEG) and Calaspargase Pegol (SC-PEG) in Pediatric Patients with Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma: Results of DFCI ALL Consortium Protocol 11-001

Lewis B. Silverman - American Society of Hematology (ASH) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

Erwinase

Autoimmune Hemolytic Anemia Confers Risk of Thromboembolism That Is Not Attributable to Usual Thrombosis Risk Factors: A Longitudinal, Retrospective Cohort Study Using the Stride Database

Evan C. Chen - American Society of Hematology (ASH) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

N/A

The Role of Whole-Body Magnetic Resonance Imaging (WB-MRI) in Patients witha Paroxysmal Nocturnal Hemoglobinuria (PNH)

Ferras Alashkar - American Society of Hematology (ASH) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Eculizumab

Calcium Independent Events Trigger VWF-Dependent Shear-Induced Procoagulant Platelet Formation

Andaleb Kholmukhamedov - American Society of Hematology (ASH) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Cyclosporine eent

Markers of Autoimmunity in Immune Thrombocytopenia: Prevalence and Prognostic Significance

Marie A Hollenhorst - American Society of Hematology (ASH) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

N/A

Inherited Factor XI Deficiency Is Associated with Decrease Risk for Cardiovascular Adverse Event and Venous Thromboembolisma - Israeli Population Based Study

Meir Preis - American Society of Hematology (ASH) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Biomarkers of Inflammation and Infection in Sepsis Associated Disseminated Intravascular Coagulation and Their Prognostic Role

Priya Patel - American Society of Hematology (ASH) , 2016

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Venous thrombosis

Interleukin-10

Early Low Level Hemolysis Is Associated with Subsequent Device Thrombosis and Ischemic Stroke during Continuous Flow Left Ventricular Assist Device Support By the Heart Mate II

Omar Saeed - American Society of Hematology (ASH) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Warfarin

Natural Killer Cells Induce the Formation of Neutrophil Extracellular Traps (NETs) in Venous Thrombosis

Francois-Rene Bertin - American Society of Hematology (ASH) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Secondary Polycythemia and the Risk of Venous Thromboembolism (VTE) Among Hospitalized Patients in the United States

Smith Giri - American Society of Hematology (ASH) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

Markers for Increased Thrombotic Risk within the Complete Blood Count

Sigrun H. Lund - American Society of Hematology (ASH) , 2016

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

N/A

Filters

7277 Abstracts